Large-scale proteomic study identifies protein signatures linked to hypertension and potential therapeutic targets.
This large-scale proteomic study revealed protein signatures of BP traits and hypertension risk, highlighting inflammation and cardiac and vascular remodeling processes; NHERF2 and several other proteins emerged as promising therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Aggarwal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: